Table 2. Multiple linear regression analysis of AST, ALT and albumin in angiography patients.
| Variable | AST | ALT | Albumin |
|---|---|---|---|
| Beta (p) | Beta (p) | Beta (p) | |
| Female (vs male) | −0.192 (0.067) | −0.154 (0.125) | −0.097 (0.402) |
| Aspirin (vs none) | 0.218 (0.049) | 0.264 (0.015) | −0.028 (0.820) |
| Age | 0.438 (0.000) | −0.531 (0.000) | −2.079 (0.041) |
| Critical CAD (vs none) | 0.094 (0.492) | 0.008 (0.951) | 3.205 (0.002) |
| Non-critical CAD (vs none) | 0.151 (0.243) | 0.021 (0.865) | 1.642 (0.105) |
| Adjusted r-square | 0.174 | 0.242 | 0.124 |
| n | 88 | 87 | 76 |
AST: aspartate aminotransferase; ALT: alanine aminotransferase; CAD: coronary artery disease